VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Structure Therapeutics Inc. (GPCR) Total Return Calculator with Dividends Reinvested

Structure Therapeutics Inc.

Popular:

The total return for Structure Therapeutics Inc. (GPCR) stock is +61.23% over the past 12 months. So far it's down 40.05% this year. The 5-year total return is +57.08%, meaning $10,000 invested in GPCR stock 5 years ago would be worth $15,708 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in GPCR 1 year ago, it would be worth $15,353 today — you'd have gained $5,353.

With Dividends Reinvested$15,353+53.53%

Price Only (No DRIP)$15,353+53.53%

Period2025-05-07 → 2026-05-06

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in GPCR

1Y$16,123+$6,123 (+61.2%)61.2% CAGR

3Y$17,017+$7,017 (+70.2%)19.4% CAGR

5Y$15,708+$5,708 (+57.1%)9.5% CAGR

10Y$15,708+$5,708 (+57.1%)4.6% CAGR

15Y$15,708+$5,708 (+57.1%)3.1% CAGR

20Y$15,708+$5,708 (+57.1%)2.3% CAGR

30Y$15,708+$5,708 (+57.1%)1.5% CAGR

Structure Therapeutics Inc. did not pay dividends during this period. Total return = price return.

Loading GPCR total return...

As of 2026-05-07

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-40.05%	—	-40.05%	—	$5,995
1Y	+61.23%	61.23%	+61.23%	—	$16,123
3Y	+70.17%	19.39%	+70.17%	—	$17,017
5Y	+57.08%	9.45%	+57.08%	—	$15,708
10Y	+57.08%	4.62%	+57.08%	—	$15,708
15Y	+57.08%	3.06%	+57.08%	—	$15,708
20Y	+57.08%	2.28%	+57.08%	—	$15,708
30Y	+57.08%	1.52%	+57.08%	—	$15,708

Risk & Highlights

Best Year+146.72%2025

Worst Year-32.85%2024

Max Drawdown-55.90%2026-01-21 → 2026-05-06

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-7.55%	-7.55%	—	+0.41%	-8.0pp
2025	+146.72%	+146.72%	—	+16.64%	+130.1pp
2024	-32.85%	-32.85%	—	+24.00%	-56.9pp
2023	+56.77%	+56.77%	—	+24.81%	+32.0pp

GPCR outperformed the S&P 500 by 29.91pp over the past year (+61.23% vs +31.32%).

Loading summary...

GPCR Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
GPCRStructure Therapeutics Inc.	$2.4B	-21.1%	-40.0%	+61.2%	—	+70.2%	+57.1%	+57.1%
CHRSCoherus Oncology, Inc.	$212M	+4.8%	+27.7%	+88.2%	—	-78.5%	-87.9%	-90.9%
RVMDRevolution Medicines, Inc.	$32.1B	+58.2%	+91.2%	+303.5%	—	+518.1%	+420.9%	+422.7%
KYMRKymera Therapeutics, Inc.	$7.0B	+1.2%	+18.6%	+201.9%	—	+211.0%	+110.5%	+159.4%
ARWRArrowhead Pharmaceuticals, Inc.	$11.1B	+29.5%	+16.7%	+505.0%	—	+95.6%	+20.5%	+1315.7%
CGEMCullinan Therapeutics, Inc.	$903M	+0.5%	+48.1%	+91.0%	—	+57.6%	-48.3%	-49.9%
VKTXViking Therapeutics, Inc.	$3.7B	-4.9%	-8.9%	+19.5%	—	+41.2%	+459.4%	+2503.2%
PEPGPepGen Inc.	$127M	+1.4%	-74.3%	+43.0%	—	-87.7%	-85.7%	-85.7%
NVONovo Nordisk A/S	$203.4B	+24.8%	-10.2%	-28.2%	+2.8pp	-40.7%	+39.0%	+105.1%
LLYEli Lilly and Company	$932.6B	+6.5%	-8.5%	+28.2%	+0.8pp	+131.9%	+421.4%	+1271.7%
TERNTerns Pharmaceuticals, Inc.	$4.6B	+0.4%	+32.1%	+1659.7%	—	+302.8%	+229.8%	+188.0%

Compare:GPCR vs CHRS GPCR vs RVMD GPCR vs KYMR GPCR vs CHRS vs RVMD

About GPCR Dividend Returns

Structure Therapeutics Inc. (GPCR) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of GPCR over the past year?

Structure Therapeutics Inc. (GPCR) delivered a return of 61.23% over the past year. Since GPCR does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in GPCR be worth today?

A $10,000 investment in Structure Therapeutics Inc. one year ago would be worth $16,123 today, representing a gain of $6,123.

Q3Does GPCR pay dividends?

Structure Therapeutics Inc. (GPCR) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For GPCR, the total return equals the price-only return.

Q4Did GPCR beat the S&P 500?

Yes, Structure Therapeutics Inc. (GPCR) outperformed the S&P 500 by 29.91 percentage points over the past year. GPCR delivered a total return of 61.23%, compared to the S&P 500's 31.32%. This 29.91pp alpha means investors in GPCR earned more than a passive S&P 500 index fund.

Q5What is GPCR's worst drawdown?

Structure Therapeutics Inc. (GPCR) experienced a maximum drawdown of -55.90% over the past year, declining from its peak on 2026-01-21 to its trough on 2026-05-06. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is GPCR's long-term total return over 10, 20, or 30 years?

Here are Structure Therapeutics Inc. (GPCR)'s long-term returns with dividends reinvested. Over 10 years, the total return is 57.1% (4.6% CAGR) — $10,000 would have grown to $15,708. Over 20 years: 57.1% total return (2.3% CAGR) — $10,000 → $15,708. Over 30 years: 57.1% total return (1.5% CAGR) — $10,000 → $15,708. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was GPCR's best and worst year?

Structure Therapeutics Inc.'s best calendar year was 2025 with a total return of 146.7%. Its worst year was 2024 with a total return of -32.9%. This range shows the volatility investors should expect — the difference between the best and worst year is 179.6 percentage points.